Pharmaceutical Products Companies By Shares Shorted
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Number Of Shares Shorted
| Number Of Shares Shorted | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | VTRS | Viatris | 0.10 | 2.26 | 0.22 | ||
| 2 | DVAX | Dynavax Technologies | 0.07 | 2.46 | 0.16 | ||
| 3 | EDIT | Editas Medicine | (0.16) | 4.12 | (0.64) | ||
| 4 | VERV | Verve Therapeutics | 0.01 | 4.56 | 0.02 | ||
| 5 | NWBO | Northwest Biotherapeutics | (0.09) | 3.45 | (0.30) | ||
| 6 | ELAN | Elanco Animal Health | (0.04) | 2.57 | (0.09) | ||
| 7 | VKTX | Viking Therapeutics | (0.05) | 5.12 | (0.24) | ||
| 8 | VERU | Veru Inc | (0.07) | 3.93 | (0.29) | ||
| 9 | VXRT | Vaxart Inc | (0.15) | 3.53 | (0.53) | ||
| 10 | ELAB | Elevai Labs, Common | (0.18) | 15.30 | (2.74) | ||
| 11 | VTYX | Ventyx Biosciences | (0.09) | 3.69 | (0.32) | ||
| 12 | VRNA | Verona Pharma PLC | 0.21 | 2.99 | 0.62 | ||
| 13 | DNLI | Denali Therapeutics | 0.00 | 3.41 | 0.00 | ||
| 14 | ELVN | Enliven Therapeutics | 0.05 | 2.68 | 0.14 | ||
| 15 | VERA | Vera Therapeutics | 0.11 | 3.79 | 0.41 | ||
| 16 | ENSC | Ensysce Biosciences | 0.08 | 23.78 | 1.79 | ||
| 17 | ELEV | Elevation Oncology | (0.07) | 4.52 | (0.32) | ||
| 18 | DNTH | Dianthus Therapeutics | (0.10) | 3.82 | (0.37) | ||
| 19 | VRTX | Vertex Pharmaceuticals | (0.05) | 1.72 | (0.09) | ||
| 20 | VRCA | Verrica Pharmaceuticals | (0.10) | 9.38 | (0.97) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up. If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.